Eric J. Small, MD, presented “M0 Space and The SPARTAN Trial,” followed by a discussion with E. David Crawford, MD.
M0 Space and The SPARTAN Trial
Eric J. Small, MD, defines nonmetastatic castration-resistant prostate cancer, or M0 disease. He then discusses the design, implementation, and results of the SPARTAN trial, which he also presented at the 2018 Genitourinary Cancers Symposium. The study tested the efficacy of apalutamide in men with M0 disease.
Following this overview, Dr. Small answers questions from D. David Crawford, MD.